HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial

Khatija Ahmed(University of California, San Francisco), Julia D Welch(Family Health International 360), Katherine K. Thomas(University of Namur), G Justus Hofmeyr(Western Cape Department of Health), Margaret P. Kasaro(University of North Carolina at Chapel Hill), Jeffrey S. A. Stringer(University of North Carolina at Chapel Hill), Melanie Pleaner, Gonasagrie Nair, Elizabeth A. Bukusi(University of California, San Francisco), Petrus S. Steyn, Zelda Nhlabatsi, Nelly Mugo(University of Washington), Kavita Nanda(RTI International), Helen Rees(Institute of Mental Health), Maricianah Onono(Kenya Medical Research Institute), Linda‐Gail Bekker(Desmond Tutu HIV Foundation), Mandisa Singata‐Madliki, Raesibe Agnes Pearl Selepe, Caitlin W. Scoville, Peter Gichangi(Technical University of Mombasa), Kathleen Shears, Mags Beksinska, Douglas Taylor, Jared M. Baeten(University of Washington), Deborah Donnell(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Jessica Justman(Columbia University Irving Medical Center), Thesla Palanee‐Phillips(University of the Witwatersrand), Kate B. Heller(University of Washington), Timothy D. Mastro(Family Health International 360), Sydney Sibiya, Jennifer Smit(Janssen (United States)), Charles Morrison(Family Health International 360), Cheryl Louw, James Kiarie(World Health Organization)
The Lancet
June 13, 2019
Cited by 306


Related Papers